ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,417 | +64.2% | 11,569 | 0.0% | 0.00% | – |
| Q1 2023 | $25,221 | -82.3% | 11,569 | -2.2% | 0.00% | – |
| Q4 2022 | $142,339 | +58.2% | 11,832 | -15.0% | 0.00% | – |
| Q3 2022 | $90,000 | +45.2% | 13,925 | +2.1% | 0.00% | – |
| Q2 2022 | $62,000 | -97.5% | 13,640 | -95.2% | 0.00% | – |
| Q1 2022 | $2,443,000 | -29.6% | 282,378 | +16.1% | 0.00% | -100.0% |
| Q4 2021 | $3,472,000 | -30.1% | 243,125 | +7.7% | 0.00% | 0.0% |
| Q3 2021 | $4,964,000 | +75.8% | 225,831 | +7.0% | 0.00% | – |
| Q2 2021 | $2,824,000 | +5034.5% | 211,082 | +1055.4% | 0.00% | – |
| Q4 2018 | $55,000 | -37.5% | 18,269 | +1.4% | 0.00% | – |
| Q3 2018 | $88,000 | – | 18,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |